nodes	percent_of_prediction	percent_of_DWPC	metapath
Lindane—GLRA2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.0541	0.0956	CbGpPWpGaD
Lindane—GLRA3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.0541	0.0956	CbGpPWpGaD
Lindane—GLRA3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.0482	0.0852	CbGpPWpGaD
Lindane—GLRA2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.0482	0.0852	CbGpPWpGaD
Lindane—GLRB—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.0441	0.0779	CbGpPWpGaD
Lindane—GLRB—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.0393	0.0694	CbGpPWpGaD
Lindane—GLRA1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.0349	0.0616	CbGpPWpGaD
Lindane—GLRA1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.0311	0.0549	CbGpPWpGaD
Lindane—Dermatitis contact—Aminophylline—chronic obstructive pulmonary disease	0.0301	0.0693	CcSEcCtD
Lindane—Dermatitis contact—Arformoterol—chronic obstructive pulmonary disease	0.0229	0.0527	CcSEcCtD
Lindane—Dermatitis contact—Formoterol—chronic obstructive pulmonary disease	0.0229	0.0527	CcSEcCtD
Lindane—GLRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.0188	0.0333	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.0188	0.0333	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.0168	0.0296	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.0168	0.0296	CbGpPWpGaD
Lindane—GLRB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.0153	0.0271	CbGpPWpGaD
Lindane—GABRB1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.0145	0.0256	CbGpPWpGaD
Lindane—GLRB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.0137	0.0242	CbGpPWpGaD
Lindane—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.0135	0.0311	CcSEcCtD
Lindane—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.0129	0.0298	CcSEcCtD
Lindane—GABRB1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.0129	0.0228	CbGpPWpGaD
Lindane—GLRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.0121	0.0214	CbGpPWpGaD
Lindane—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.0115	0.0266	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.0108	0.0191	CbGpPWpGaD
Lindane—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.0108	0.0248	CcSEcCtD
Lindane—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.0103	0.0236	CcSEcCtD
Lindane—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0102	0.0235	CcSEcCtD
Lindane—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00919	0.0212	CcSEcCtD
Lindane—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00862	0.0199	CcSEcCtD
Lindane—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00859	0.0198	CcSEcCtD
Lindane—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00813	0.0187	CcSEcCtD
Lindane—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00768	0.0177	CcSEcCtD
Lindane—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00727	0.0167	CcSEcCtD
Lindane—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00724	0.0167	CcSEcCtD
Lindane—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00718	0.0165	CcSEcCtD
Lindane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00708	0.0125	CbGpPWpGaD
Lindane—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00707	0.0163	CcSEcCtD
Lindane—Pain—Formoterol—chronic obstructive pulmonary disease	0.00707	0.0163	CcSEcCtD
Lindane—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00701	0.0161	CcSEcCtD
Lindane—Pain—Montelukast—chronic obstructive pulmonary disease	0.00692	0.0159	CcSEcCtD
Lindane—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00684	0.0158	CcSEcCtD
Lindane—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0068	0.0157	CcSEcCtD
Lindane—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00677	0.0156	CcSEcCtD
Lindane—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00667	0.0154	CcSEcCtD
Lindane—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00656	0.0151	CcSEcCtD
Lindane—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00656	0.0151	CcSEcCtD
Lindane—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00645	0.0149	CcSEcCtD
Lindane—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00643	0.0148	CcSEcCtD
Lindane—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00641	0.0148	CcSEcCtD
Lindane—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.0062	0.0143	CcSEcCtD
Lindane—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00585	0.0135	CcSEcCtD
Lindane—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00585	0.0135	CcSEcCtD
Lindane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00577	0.0102	CbGpPWpGaD
Lindane—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00573	0.0132	CcSEcCtD
Lindane—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00552	0.0127	CcSEcCtD
Lindane—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00546	0.0126	CcSEcCtD
Lindane—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00546	0.0126	CcSEcCtD
Lindane—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00535	0.0123	CcSEcCtD
Lindane—GABRB1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00532	0.0094	CbGpPWpGaD
Lindane—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.0052	0.012	CcSEcCtD
Lindane—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.0052	0.012	CcSEcCtD
Lindane—Headache—Formoterol—chronic obstructive pulmonary disease	0.00518	0.0119	CcSEcCtD
Lindane—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00518	0.0119	CcSEcCtD
Lindane—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00516	0.0119	CcSEcCtD
Lindane—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0051	0.0117	CcSEcCtD
Lindane—Headache—Montelukast—chronic obstructive pulmonary disease	0.00507	0.0117	CcSEcCtD
Lindane—GABRB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00504	0.0089	CbGpPWpGaD
Lindane—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00491	0.0113	CcSEcCtD
Lindane—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00489	0.0113	CcSEcCtD
Lindane—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00475	0.0109	CcSEcCtD
Lindane—GABRB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00449	0.00793	CbGpPWpGaD
Lindane—GABRB1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00434	0.00767	CbGpPWpGaD
Lindane—GABRB1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00408	0.00721	CbGpPWpGaD
Lindane—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00404	0.00932	CcSEcCtD
Lindane—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00402	0.00926	CcSEcCtD
Lindane—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00383	0.00882	CcSEcCtD
Lindane—GLRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00369	0.00653	CbGpPWpGaD
Lindane—GLRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00369	0.00653	CbGpPWpGaD
Lindane—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00355	0.00819	CcSEcCtD
Lindane—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00345	0.00795	CcSEcCtD
Lindane—GABRB1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00332	0.00587	CbGpPWpGaD
Lindane—GLRB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00301	0.00532	CbGpPWpGaD
Lindane—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00296	0.00682	CcSEcCtD
Lindane—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00292	0.00673	CcSEcCtD
Lindane—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00282	0.00649	CcSEcCtD
Lindane—Headache—Prednisolone—chronic obstructive pulmonary disease	0.0028	0.00646	CcSEcCtD
Lindane—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00258	0.00595	CcSEcCtD
Lindane—GLRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00238	0.0042	CbGpPWpGaD
Lindane—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.0023	0.0053	CcSEcCtD
Lindane—GLRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00222	0.00392	CbGpPWpGaD
Lindane—GLRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00222	0.00392	CbGpPWpGaD
Lindane—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00215	0.00495	CcSEcCtD
Lindane—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00205	0.00472	CcSEcCtD
Lindane—Headache—Prednisone—chronic obstructive pulmonary disease	0.00204	0.00469	CcSEcCtD
Lindane—GLRB—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00181	0.00319	CbGpPWpGaD
Lindane—GLRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00143	0.00252	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000988	0.00175	CbGpPWpGaD
Lindane—GABRB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000593	0.00105	CbGpPWpGaD
